| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064731A1 Nonsolvated crystals of polymethine compound, process for production thereof and use of the crystals |
| 06/22/2006 | WO2006064304A1 Acid addition salts of muscarinic receptor antagonists |
| 06/22/2006 | WO2006064179A1 Process and intermediate compounds useful in the preparation of statins |
| 06/22/2006 | WO2006064044A1 Indolinones and their use as antiproliferative agents |
| 06/22/2006 | WO2006063863A1 Biaromatic compounds that modulate ppar type receptors, process for preparing them and use thereof in cosmetic or pharmaceutical compositions |
| 06/22/2006 | WO2005094897A3 Pegylated ion channel modulating compounds |
| 06/22/2006 | WO2005087731A8 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 06/22/2006 | US20060135812 Thiol-based NAALADase inhibitors |
| 06/22/2006 | US20060135789 Process for the preparation of gabalactam |
| 06/22/2006 | US20060135783 Multifunctional amine capture agents |
| 06/22/2006 | US20060135620 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 06/22/2006 | US20060135594 Dihydropyrrole derivatives; 3-{(2S)-4-(2,5-difluorophenyl)-1-[(dimethylamino)carbonyl]-2,5-dihydro- 1H-pyrrol-2-yl}phenyl dihydrogen phosphate; anticarcinogenic agents; cellular proliferative diseases; specificity; side effect reduction |
| 06/22/2006 | US20060135592 Indolinones and their use as antiproliferative agents |
| 06/22/2006 | US20060135591 Modulators of CRTH2 activity |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135480 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 06/22/2006 | US20060134425 Organic luminescence device (OLED) containing both a 5,5'-spirobi(dibenzosilole) compound and a diarylaminofluorene compound; spiro compounds have improved electron-transporting property, luminescence, and durability |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2589501A1 Indolinones and their use as antiproliferative agents |
| 06/22/2006 | CA2588389A1 Substituted phenols as active agents inhibiting vegf production |
| 06/21/2006 | EP1670909A2 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
| 06/21/2006 | EP1670804A2 Heterobicyclic compounds as pharmaceutically active agents |
| 06/21/2006 | EP1670778A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | EP1670759A1 PROCESS FOR THE PREPARATION OF (1a, 5a, 6a)-6-AMINOME THYL-3-BENZYL-3-AZABICYCLO 3.1.0 HEXANE |
| 06/21/2006 | EP1670758A1 Substituted indole acid derivatives and their use as pai-1 inhibitors |
| 06/21/2006 | EP1670485A1 Treatment of diseases associated with the egr-1 enhancer element |
| 06/21/2006 | EP1670459A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 06/21/2006 | EP1670458A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | EP1670444A2 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1303306B1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 06/21/2006 | EP1255734B1 Isatine derivatives with neurotrophic activity |
| 06/21/2006 | EP1146037B1 Process for the preparation of optically active amino alcohols |
| 06/21/2006 | EP1123278B1 Method for producing (+)-exo-6-phenyl-3-azabicyclo- 3.2.0|heptanes |
| 06/21/2006 | EP0957080B1 Novel ethylamine derivatives |
| 06/21/2006 | CN1791577A Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin D2 antagonists |
| 06/21/2006 | CN1791576A Benzamide modulators of metabotropic glutamate receptors |
| 06/21/2006 | CN1791407A [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists |
| 06/21/2006 | CN1791402A Ophthalmic compositions for treating ocular hypertension |
| 06/21/2006 | CN1791401A Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof |
| 06/21/2006 | CN1789262A Improvement of preparation of Naratriptan |
| 06/21/2006 | CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 06/21/2006 | CN1789240A 2-substituted amido dicarboxylic acid, its preparation method and use |
| 06/21/2006 | CN1260230C Production process of camptothecin |
| 06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
| 06/21/2006 | CN1260214C Heterofluorene highly branched derivative with strong two photon absorption characteristics |
| 06/20/2006 | US7064219 aldol reacting indole-3-pyruvic acid and oxalacetic acid/pyruvic acid and decarboxylating; for producing monatin for use in sweeteners and drugs |
| 06/20/2006 | US7064218 Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity |
| 06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
| 06/20/2006 | US7064143 4-oxy- or amino-substituted indole-2-carboxy acids, esters and amides, e.g., ethyl 4-hydroxy-1-methyl-1H-indole-2-carboxylate and N-methyl-N-phenethyl 4-hydroxy-1-methyl-1H-indole-2-carboxamide; used for treatment of Alzheimer's disease, anxiety or schizophrenia |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | US7064117 Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006062580A1 Indane amides with antiproliferative activity |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006061493A1 Substituted indoles, compositions containing them, method for the production thereof and their use |
| 06/15/2006 | WO2006061415A1 2,4 (4,6) pyrimidine derivatives |
| 06/15/2006 | WO2006061392A2 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 06/15/2006 | WO2006061364A1 Process for the preparation of carvedilol and its enantiomers |
| 06/15/2006 | US20060128961 Process for the production of meso-substituted cyanine dyes |
| 06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/15/2006 | US20060128903 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/15/2006 | US20060128788 Purification of tegaserod maleate |
| 06/15/2006 | US20060128787 Acyl-CoA: cholesterol acyltransferase and lipoxygenase inhibitors; superior oral absorbability; strong antihyperlipidemia effect and an anti-arteriosclerosis effect; N-(5-methanesulfonylamino-4,6-dimethyl-1-propylindolin-7-yl)-2,2-dimethylpropanamide |
| 06/15/2006 | US20060128786 Compounds for the treatment of alzheimer's disease |
| 06/15/2006 | US20060128785 diindole compounds as anticancer agents; potentiation; effective against estrogen-dependent, estrogen-independent, drug-resistant and/or metastasized cancers |
| 06/15/2006 | US20060128784 Bis-heteroaryl alkanes as therapeutic agents |
| 06/15/2006 | US20060128783 Tyrosine kinase inhibitors |
| 06/15/2006 | US20060128722 Indoles useful in the treatment of androgen-receptor related diseases |
| 06/15/2006 | US20060128687 Lactam glycogen phosphorylase inhibitors and method of use |
| 06/15/2006 | CA2589699A1 Process for the preparation of carvedilol and its enantiomers |
| 06/15/2006 | CA2588761A1 2,4(4,6)pyrimidine derivatives |
| 06/15/2006 | CA2588760A1 Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | CA2586991A1 Substituted indoles, compositions containing them, method for the production thereof and their use |
| 06/15/2006 | CA2584307A1 Indane amides with antiproliferative activity |
| 06/14/2006 | EP1669345A1 Ester derivative and medicinal use thereof |
| 06/14/2006 | EP1667990A2 New compounds |
| 06/14/2006 | EP1667970A1 Heterocyclic- or aryloxy, -thio 0r -amino substituted indoles-2-carboxylic acids or esters as pai-1 inhibitors |
| 06/14/2006 | EP1667969A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 06/14/2006 | EP1667968A1 Processes for the preparation ofa polymorph of fluvastatin sodium |
| 06/14/2006 | EP1667959A1 Biphenyloxy-acids |
| 06/14/2006 | EP1667678A1 Animal feed composition |
| 06/14/2006 | EP1667670A1 4-(1h-indol-3-yl-methylideneaminoxy-propoxy)-benzoic acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairement of the fibrinolytic system and of thrombisis |
| 06/14/2006 | EP1587877B1 Beta-isoindigo coloring agent |
| 06/14/2006 | EP1572696B1 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones |
| 06/14/2006 | EP1497292B1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 06/14/2006 | EP1349836B1 Tetracyclic derivatives as spla2 inhibitors |
| 06/14/2006 | EP1341759B1 3-substituted oxindole beta 3 agonists |
| 06/14/2006 | EP1339683B1 Estrogen receptor modulators |
| 06/14/2006 | EP1157704B1 Spla2 inhibitors for the treatment of ischaemic reperfusion injury |
| 06/14/2006 | EP1017675B1 Highly lipophilic camptothecin derivatives |
| 06/14/2006 | CN1787995A Alpha, omega-dicarboximide derivatives as useful uro-selective alpha1alpha adrenoceptor blockers |
| 06/14/2006 | CN1787994A 2,4,6-phenyl substituted cyclic ketoenols |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1787988A Arylamine compound and organic electroluminescence device containing the same |
| 06/14/2006 | CN1785975A Synthesis method of beta indolone |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |